Ocuphire Pharma Profit Margin

Ocuphire Pharma (OCUP) currently reports a profit margin of -2099.71% as of June 2026. That compares with 9429.06% in the prior-year period — down 122.3% year over year. That is below the Healthcare sector average of 13.89%. Use the charts on this page to explore Ocuphire Pharma's profit margin history and peer comparisons.

Ocuphire Pharma's profit margin decreased from 9429.06% to -2099.71% — a 122.3% year-over-year decrease (period ending June 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Ocuphire Pharma's profit margin of -2099.71% is lower than the Healthcare sector average of 13.89%. That is roughly 15213.3% below the sector mean. A reading lower peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.

There is no universal 'good' profit margin, but Ocuphire Pharma's current -2099.71% should be judged against Healthcare norms (sector average: 13.89%) and against OCUP's own history. Strong, stable readings often indicate durable competitive advantage; volatile or declining ones deserve a closer look at margins and capital efficiency.

Start with the current profit margin of -2099.71%, then check the historical chart for trend and the peer comparison chart for relative positioning. The Healthcare average is 13.89%. From there, open related valuation or income-statement pages for Ocuphire Pharma, and consider following OCUP for alerts when major investors trade the stock.